Blog

BPC-157: The Complete Researcher’s Guide to the Body Protection Compound

Posted by

peptidecu

May 22, 2026

On May 22, 2026

📋 TABLE OF CONTENTS

What Is BPC-157?
Mechanism of Action
Key Research Applications
Forms & Specifications
Storage & Reconstitution
Sourcing & Quality Standards
Frequently Asked Questions

What Is BPC-157?

BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide — a chain of 15 amino acids — derived from a protein found in human gastric juice. Its full sequence is: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. The molecular formula is C₆₂H₉₈N₁₆O₂₂, with a molecular weight of approximately 1,419 Da.

First isolated and characterized by researchers at the University of Zagreb in the early 1990s, BPC-157 has been the subject of extensive preclinical research across multiple organ systems. What distinguishes it from many research peptides is its remarkable stability in biological environments — unlike many peptides that degrade rapidly in gastric acid, BPC-157 maintains activity even under acidic conditions, a property attributed to its gastric origin.

🔑 KEY FACT

BPC-157 is categorized as a research compound. All peer-reviewed studies to date have been conducted in animal models (primarily rats). It has not been approved by the FDA or any equivalent regulatory body for human therapeutic use.

Mechanism of Action

BPC-157’s biological effects appear to operate through several converging pathways, which may explain its broad activity across different tissue types in preclinical models. The primary mechanisms identified in research literature include:

🩸

Angiogenesis Promotion

BPC-157 has been shown in multiple animal studies to upregulate VEGF (Vascular Endothelial Growth Factor) expression, stimulating the formation of new blood vessels — a key process in tissue repair and regeneration.

🔧

Tendon & Ligament Repair

Research demonstrates BPC-157’s influence on tendon fibroblast activity and collagen synthesis. Studies using rat Achilles tendon transection models have reported accelerated healing compared to controls.

🧠

Nitric Oxide Modulation

The compound appears to modulate the NO (nitric oxide) system, influencing vascular tone, inflammation regulation, and neurological signaling pathways in preclinical models.

🛡️

Gastrointestinal Protection

Derived from gastric juice protein, BPC-157 has demonstrated cytoprotective effects on gastrointestinal mucosa in animal studies, including models of colitis, stomach ulcers, and bowel inflammation.

Key Research Applications

The breadth of BPC-157’s preclinical research profile is unusual among synthetic peptides. Below are the primary areas where published animal studies have demonstrated notable activity:

Musculoskeletal & Connective Tissue Research

Perhaps the most extensively studied area, BPC-157 has shown consistent effects on tendon, ligament, muscle, and bone healing in rodent models. A landmark 2010 study published in the Journal of Orthopaedic Research demonstrated significantly accelerated Achilles tendon healing in rats treated with BPC-157 versus saline controls — with improved tensile strength and earlier vascularization at the repair site.

Gastrointestinal Research

Given its natural origin in gastric juice, the GI protective effects of BPC-157 have been among the earliest and most reproducible findings. Multiple studies have explored its effects in models of chemically-induced colitis, gastric ulceration, esophageal damage, and NSAID-induced gut injury.

Neurological Research

A growing body of animal research has examined BPC-157’s effects on the central nervous system. Studies have investigated its influence on dopaminergic and serotonergic systems, with some rodent models showing anxiolytic and neuroprotective effects. Traumatic brain injury and spinal cord injury models have also been explored.

Research Area	Model Used	Key Finding (Preclinical)
Tendon healing	Rat Achilles transection	Accelerated repair, improved tensile strength
GI protection	Rat colitis / ulcer model	Reduced mucosal damage, faster ulcer resolution
Wound healing	Rat cutaneous wound model	Enhanced angiogenesis, faster wound closure
Neurological	Rat TBI / dopamine models	Neuroprotective effects, behavioral improvements
Bone healing	Rat femoral defect	Increased bone mineral density at repair site

Forms & Specifications

BPC-157 is available in two primary forms for research applications, each with distinct advantages depending on the intended protocol:

ACETATE SALT FORM

Most commonly used in research
Water-soluble — easier reconstitution
Suitable for most standard protocols
Typically ≥98% purity (HPLC)
Available: 5mg, 10mg vials

ARGINATE FORM (BPC-157 ARG)

More stable salt form
Improved oral bioavailability in models
Preferred for GI-focused research
Typically ≥98% purity (HPLC)
Available: 5mg, 10mg vials

Storage & Reconstitution Protocol

Storage Conditions

🧊

Lyophilized (Unopened)

−20°C
Up to 24 months

❄️

Reconstituted

2–8°C
Use within 28 days

⚠️

Avoid

Light, heat
Freeze-thaw cycles

Reconstitution Steps

1
Allow the lyophilized vial to reach room temperature before opening (≈5 minutes).

2
Use bacteriostatic water (BAC water) as the solvent. Draw the required volume into a sterile syringe.

3
Inject the BAC water slowly along the side of the vial wall — do not inject directly onto the powder.

4
Gently swirl (do not vortex or shake) until the powder is fully dissolved. The solution should be clear.

5
Store reconstituted solution at 2–8°C. Label with the reconstitution date. Use within 28 days.

Sourcing & Quality Standards

For any research application, the quality and purity of your peptide source directly determines the reliability of your results. When sourcing BPC-157, researchers should look for the following documentation as a minimum standard:

📋

COA

Certificate of Analysis with purity, batch number, and test date

📈

HPLC Report

High-performance liquid chromatography data confirming purity ≥98%

⚖️

MS Data

Mass spectrometry confirming molecular weight matches theoretical value

✅ MZC QUALITY STANDARD

All MZC BPC-157 products are supplied with a full Certificate of Analysis including third-party HPLC and MS data. Purity is ≥98% on every batch. COA documents are available on the product page and shipped physically with every order.

Frequently Asked Questions

Is BPC-157 the same as BPC-157 Arginate?

No. BPC-157 acetate and BPC-157 arginate (BPC-157 ARG) are different salt forms of the same peptide sequence. The arginate form uses arginine as the counter-ion and is considered more stable, with potentially improved oral bioavailability based on animal data.

What concentration should I use for cell culture research?

Concentrations used in in vitro studies have varied widely, from 1 nM to 100 μM depending on the cell type and endpoint being measured. We recommend reviewing the specific literature for your research area and consulting your institutional protocol guidelines.

Does BPC-157 need to be stored cold during shipping?

Lyophilized BPC-157 is stable at ambient temperatures for short transit periods (up to 2–3 weeks). However, upon receipt, it should be immediately placed in −20°C storage. MZC ships all peptides with appropriate protective packaging for air freight transit.

Are there published human clinical trials on BPC-157?

As of 2025, the overwhelming majority of published BPC-157 research consists of animal studies, primarily in rodent models. A limited number of human case reports exist in the literature. No large-scale randomized controlled human clinical trials have been completed and published in peer-reviewed journals.

⚠️ RESEARCH USE DISCLAIMER

This article is intended for informational and educational purposes for qualified researchers only. BPC-157 is a research compound sold by MZC strictly for laboratory and scientific research use. It is not approved for human consumption, diagnosis, treatment, or prevention of any condition. All referenced studies are preclinical animal models. Researchers are responsible for ensuring compliance with all applicable regulations in their jurisdiction.

MZC Research Editorial Team

Peptide Science · MZC Peptides

The MZC editorial team consists of peptide scientists and research professionals dedicated to providing accurate, evidence-based information for the global research community. All articles are reviewed against current peer-reviewed literature.